Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Northrop Grumman
NOC
|
+$305M |
| 2 |
Prologis
PLD
|
+$97.9M |
| 3 |
Carlisle Companies
CSL
|
+$29.2M |
| 4 |
Healthcare Realty
HR
|
+$28.7M |
| 5 |
Gaming and Leisure Properties
GLPI
|
+$27.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$102M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$91.2M |
| 3 |
Chevron
CVX
|
+$54.7M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$52.9M |
| 5 |
Microsoft
MSFT
|
+$27.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.12% |
| 2 | Healthcare | 15.83% |
| 3 | Consumer Discretionary | 12.65% |
| 4 | Industrials | 8.88% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Ecovyst
ECVT
$1.11B
| $1.25M | ﹤0.01% |
148,000
+2,700
| +2% | +$25.7K |
|
2202
Inogen
INGN
$154M
| $1.25M | ﹤0.01% |
51,400
+600
| +1% | +$16.6K |
|
2203
Mercer International
MERC
$33.6M
| $1.25M | ﹤0.01% |
101,472
| – | – |
|
|
GES
2204
DELISTED
Guess Inc
GES
| $1.25M | ﹤0.01% |
85,000
-7,100
| -8% | -$127K |
|
2205
Ennis
EBF
$559M
| $1.24M | ﹤0.01% |
61,800
| – | – |
|
|
MRSN
2206
DELISTED
Mersana Therapeutics
MRSN
| $1.24M | ﹤0.01% |
7,360
+240
| +3% | +$39K |
|
2207
RLX Technology
RLX
$2.47B
| $1.24M | ﹤0.01% |
1,182,989
-7,900
| -0.7% | -$12.1K |
|
|
GOLD
2208
Gold.com Inc
GOLD
$1.29B
| $1.24M | ﹤0.01% |
43,700
+700
| +2% | +$21.3K |
|
2209
RCI Hospitality Holdings
RICK
$221M
| $1.24M | ﹤0.01% |
19,000
| – | – |
|
2210
Collegium Pharmaceutical
COLL
$921M
| $1.24M | ﹤0.01% |
77,400
| – | – |
|
2211
Recursion Pharmaceuticals
RXRX
$1.76B
| $1.24M | ﹤0.01% |
116,500
+3,700
| +3% | +$37.5K |
|
|
PAYA
2212
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $1.24M | ﹤0.01% |
202,200
| – | – |
|
2213
RPC Inc
RES
$1.4B
| $1.23M | ﹤0.01% |
177,900
| – | – |
|
|
PNT
2214
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $1.23M | ﹤0.01% |
159,366
+63,800
| +67% | +$542K |
|
2215
American Vanguard Corp
AVD
$64.6M
| $1.23M | ﹤0.01% |
65,851
| – | – |
|
|
DHIL
2216
DELISTED
Diamond Hill
DHIL
| $1.23M | ﹤0.01% |
7,454
| – | – |
|
2217
EVgo
EVGO
$506M
| $1.23M | ﹤0.01% |
155,400
+82,600
| +113% | +$720K |
|
2218
HealthStream
HSTM
$835M
| $1.23M | ﹤0.01% |
57,700
-2,000
| -3% | -$45.5K |
|
|
TSVT
2219
DELISTED
2seventy bio
TSVT
| $1.22M | ﹤0.01% |
83,902
| – | – |
|
2220
Crescent Energy
CRGY
$3.95B
| $1.22M | ﹤0.01% |
90,580
+9,400
| +12% | +$138K |
|
2221
WisdomTree
WT
$3.4B
| $1.22M | ﹤0.01% |
260,700
+3,400
| +1% | +$17.4K |
|
2222
Insteel Industries
IIIN
$631M
| $1.22M | ﹤0.01% |
45,900
| – | – |
|
|
AMRS
2223
DELISTED
Amyris Inc.
AMRS
| $1.22M | ﹤0.01% |
417,000
+16,100
| +4% | +$43.9K |
|
|
THR
2224
DELISTED
Thermon Group Holdings
THR
| $1.22M | ﹤0.01% |
78,900
| – | – |
|
2225
Genesco
GCO
$393M
| $1.22M | ﹤0.01% |
30,900
-1,800
| -6% | -$96.2K |
|
Similar funds
Swiss National Bank's Q3 2022 Portfolio in Review
As of Q3 2022, Swiss National Bank held 2,744 positions worth $140B, down 5.4% from $148B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 1.2%. Swiss National Bank opened 4 new positions and exited 30, leaving the 2,744-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q3 2022 buy was Northrop Grumman: 639,945 shares worth $301M.
- Swiss National Bank added most to Prologis in Q3 2022, an estimated $97.9M increase.
- Swiss National Bank's biggest Q3 2022 reduction was Apple, cutting an estimated $102M.
- Swiss National Bank fully exited Duke Realty Corp. in Q3 2022, selling an estimated $91.2M.
- Swiss National Bank's ten largest holdings make up 26% of its $140B portfolio in Q3 2022.
- Swiss National Bank opened 4 new positions and closed 30 in Q3 2022.
- Swiss National Bank's portfolio value fell 5.4% quarter-over-quarter to $140B.
Based on Swiss National Bank's 13F filing for Q3 2022, filed 9 Nov 2022.